NewcelX Ltd. (NCEL)

CIK 0001783036 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Balance Sheets
—
Balance Sheets (P)
—
Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Operations and Comprehensive Loss
—
Statements of Operations and Comprehensive Loss (P)
—
Statements of Profit Or Loss and Other Comprehensive Loss
—
Consolidated Statements of Changes In Equity
—
Consolidated Statements of Changes In Equity (deficit)
—
Statements of Changes In Equity (deficit)
—
Consolidated Statements of Cash Flows
—
Statements of Cash Flows
—
Notes
Accounting Policies
—
Accounts Payable
—
Background
—
Business Combination
—
Commitments and Contingencies
—
Contingent Liabilities and Commitments
—
Cybersecurity Risk Management and Strategy Disclosure
—
Deferred Revenues
—
Equity
—
General
—
Income Taxes
—
Insider Trading Policies and Procedures
—
Loans and Fair Value Measurement
—
Loss Per Share
—
Note Payable
—
Other Accrued Liabilities
—
Pay Vs Performance Disclosure
—
Pension Liability
—
Prepaid Expenses and Other Accounts Receivable
—
Prepaid Expenses and Other Current Assets
—
Property and Equipment
—
Property and Equipment, Net
—
Related Parties
—
Related Party Consulting Agreements
—
Related Party Short-term Loans
—
Share Capital and Public Offerings
—
Short-term Convertible Notes
—
Subesequent Events
—
Subsequent Events
—
Summary of Significant Accounting Policies
—
Taxes On Income
—
Trade Payables
—